1. Home
  2. MLCI vs CPHI Comparison

MLCI vs CPHI Comparison

Compare MLCI & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mount Logan Capital Inc.

MLCI

Mount Logan Capital Inc.

N/A

Current Price

$3.41

Market Cap

37.6M

Sector

Finance

ML Signal

N/A

Logo China Pharma Holdings Inc.

CPHI

China Pharma Holdings Inc.

HOLD

Current Price

$0.61

Market Cap

31.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLCI
CPHI
Founded
N/A
N/A
Country
United States
China
Employees
21
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.6M
31.2M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
MLCI
CPHI
Price
$3.41
$0.61
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
30.1K
1.5M
Earning Date
05-08-2026
05-11-2026
Dividend Yield
2.63%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,144,268.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.68
$0.38
52 Week High
$8.68
$2.00

Technical Indicators

Market Signals
Indicator
MLCI
CPHI
Relative Strength Index (RSI) 52.56 41.41
Support Level $3.31 $0.52
Resistance Level $3.84 $0.68
Average True Range (ATR) 0.28 0.12
MACD 0.02 -0.01
Stochastic Oscillator 58.76 11.20

Price Performance

Historical Comparison
MLCI
CPHI

About MLCI Mount Logan Capital Inc.

Mount Logan Capital Inc operates as emerging asset management and investment firm focused on investing in public and private debt securities in the North American market. The company's reporting segments include asset management and insurance. The company through its subsidiaries, earns management and incentive fees and servicing fees for providing investment management, monitoring and other services to investment vehicles and advisers. The Asset Management segment comprises all fee generating activities. The Insurance Solutions segment, which derives maximum revenue, consists of two product lines within the insurance business, LTC and MYGA.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

Share on Social Networks: